Heart failure: preventing disease and death worldwide

ESC Heart Failure

Volumn 1, Issue 1, 2014, Pages 4-25

  Ponikowski, Piotr ^a   Anker, Stefan D ^b   AlHabib, Khalid F ^c   Cowie, Martin R ^d   Force, Thomas L ^e   Hu, Shengshou ^f   Jaarsma, Tiny ^g   Krum, Henry ^h   Rastogi, Vishal ⁱ   Rohde, Luis E ^j   Samal, Umesh C ^k   Shimokawa, Hiroaki ^l   Budi Siswanto, Bambang ^m   Sliwa, Karen ⁿ   Filippatos, Gerasimos ^o  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f FUWAI HOSPITAL   (China)

^g LINKÖPING UNIVERSITY   (Sweden)

^h MONASH UNIVERSITY   (Australia)

ⁱ ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^j HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^k Cardiological Society of India   (India)

^l TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m UNIVERSITY OF INDONESIA   (Indonesia)

ⁿ UNIVERSITY OF CAPE TOWN   (South Africa)

^o NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

more..

Author keywords

Acute heart failure; Awareness; Chronic heart failure; Epidemiology; Therapy

Indexed keywords

EID: 85003607197     PISSN: None     EISSN: 20555822     Source Type: Journal    
DOI: 10.1002/ehf2.12005     Document Type: Review

References (169)

1. Lloyd-Jones DM, Larson MG, Leip EP et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068–72
2. Rodriguez KL, Appelt CJ, Switzer GE et al. ‘They diagnosed bad heart’: a qualitative exploration of patients' knowledge about and experiences with heart failure. Heart Lung 2008;37:257–65
3. Wasywich CA, Gamble GD, Whalley GA et al. Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of ‘days alive and out of hospital’ from epidemiological data. Eur J Heart Fail 2010;12:462–8
4. Blair JE, Huffman M, Shah SJ. Heart failure in North America. Curr Cardiol Rev 2013;9:128–46
5. Damasceno A, Mayosi BM, Sani M et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012;172:1386–94
6. Robertson J, McElduff P, Pearson SA et al. The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Serv Res 2012;12:103. doi:10.1186/1472-6963-12-103
7. National University Heart Centre Singapore. Multi-centre study to examine new approach to treat patients with heart failure, 2014. Available from: www.nuhs.edu.sg/wbn/slot/news/ah01/a6a39c8fb_u4641.pdf (Accessed 28 February 2014)
8. Al-Shamiri MQ. Heart failure in the Middle East. Curr Cardiol Rev 2013;9:174–8
9. Guo Y, Lip GY, Banerjee A. Heart failure in East Asia. Curr Cardiol Rev 2013;9:112–22
10. Overbeek JA, Penning-van-Beest FJA, Herings RMC et al. Recent in-hospital mortality trends among patients with heart failure in the Netherlands. European Society of Cardiology, 27–31 August 2011, Paris, France. Available from: http://spo.escardio.org/eslides/view.aspx?eevtid=48&fp=P1788 (Accessed 28 February 2014)
11. Cowie MR, Anker SD, Cleland J et al. Improving care for patients with acute heart failure: before, during and after hospitalization. Oxford, UK: Oxford PharmaGenesis™; 2014. Available from: http://www.oxfordhealthpolicyforum.org/AHFreport (Accessed 16 April 2014)
12. Siswanto BB, Radi B, Kalim H et al. Acute decompensated heart failure in 5 hospitals in Indonesia. CVD Prev Control 2010;5:35–8
13. Bocchi EA, Arias A, Verdejo H et al. The reality of heart failure in Latin America. J Am Coll Cardiol 2013;62:949–58
14. Ministério da Saúde (Ministry of Health). DATASUS—Brazil. Health information (TABNET) [Informações de Saúde (TABNET)], Available from: http://tabnet.datasus.gov.br/ (Accessed 2 April 2014)
15. ® international benchmark report: final report, January 1, 2006–March 31, 2009; 2009
16. Barretto AC, Del Carlo CH, Cardoso JN et al. Hospital readmissions and death from heart failure—rates still alarming. Arq Bras Cardiol 2008;91:335–41
17. Moleerergpoom W, Hengrussamee K, Piyayotai D et al. Predictors of in-hospital mortality in acute decompensated heart failure (Thai ADHERE). J Med Assoc Thai 2013;96:157–64
18. Sato N, Kajimoto K, Keida T et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND registry). Circ J 2013;77:944–51
19. Hyun-Jai C, Sang Eun L, Hae-Young L et al. Lessons from acute decompensated heart failure patients in Korea (KorAHF) registry. 7th Asia Pacific Congress of Heart Failure and the Annual Scientific Meeting of Indonesian Heart Association. Bali, Indonesia. Eur J Heart Fail 2014;16(Suppl 1):1–41
20. Baselm OA, Bashin IA. Study of clinical epidemiology of heart failure cases admitted to Al-Gamhouria Teaching Hospital, Aden, Yemen. 7th Asia Pacific Congress of Heart Failure and the Annual Scientific Meeting of Indonesian Heart Association. Bali, Indonesia. In: Eur J Heart Fail 2014;16(Suppl 1):1–41
21. Cleland JG, Swedberg K, Follath F et al. The EuroHeart failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442–63
22. Maggioni AP, Dahlstrom U, Filippatos G et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013;15:808–17
23. Nieminen MS, Brutsaert D, Dickstein K et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725–36
24. AlHabib KF, Elasfar AA, Alfaleh H et al. Clinical features, management, and short- and long-term outcomes of patients with acute decompensated heart failure: phase I results of the HEARTS database. Eur J Heart Fail 2014: doi: 10.1002/ejhf.57
25. Bueno H, Ross JS, Wang Y et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA 2010;303:2141–7
26. Chen J, Dharmarajan K, Wang Y et al. National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol 2013;61:1078–88
27. Curtis LH, Greiner MA, Hammill BG et al. Early and long-term outcomes of heart failure in elderly persons, 2001–2005. Arch Intern Med 2008;168:2481–8
28. Schaufelberger M, Swedberg K, Koster M et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 2004;25:300–7
29. Jhund PS, Macintyre K, Simpson CR et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009;119:515–23
30. Joffe SW, Webster K, McManus DD et al. Improved survival after heart failure: a community-based perspective. J Am Heart Assoc 2013;2:e000053. doi: 10.1161/JAHA.113.000053
31. Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344–50
32. Tavazzi L, Senni M, Metra M et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 2013;6:473–81
33. Beattie JM. Death by oxymoron? The enigma of heart failure with preserved ejection fraction. Curr Opin Support Palliat Care 2014;8:1–3
34. Rigolli M, Whalley GA. Heart failure with preserved ejection fraction. J Geriatr Cardiol 2013;10:369–76
35. Brenner H, Bouvier AM, Foschi R et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer 2012;131:1649–58
36. Coleman MP, Forman D, Bryant H et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127–38
37. Siegel R, DeSantis C, Virgo K et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220–41
38. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30–41
39. Ambrosy AP, Fonarow GC, Butler J et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from HHF registries. J Am Coll Cardiol 2014;63:1123–33
40. International Agency for Research on Cancer. Estimated cancer incidence, mortality and prevalence worldwide in 2012 (GLOBOCAN 2012) Lyon; 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx (Accessed 28 February 2014)
41. World Health Organization. Global health observatory: HIV/AIDS Geneva; 2014. Available from: http://www.who.int/gho/hiv/en/ (Accessed 28 February 2014)
42. Okura Y, Ramadan MM, Ohno Y et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 2008;72:489–91
43. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011. Canberra, Australia: Australian Institute of Health and Welfare, 2011. Available from: http://www.aihw.gov.au/publication-detail/?id=10737418510(Accessed 28 February 2014)
44. Galinier M, Bouvet B, Rocchi M et al. What is the burden for hospitalizations in France in 2010? European Society for Cardiology, 25–29 August 2012, Munich, Germany. Available from: http://spo.escardio.org/eslides/view.aspx?eevtid=54&fp=P982 (Accessed 28 February 2014)
45. Heidenreich PA, Albert NM, Allen LA et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013;6:606–19
46. Cleland J, Dargie H, Hardman S et al. National heart failure audit April 2012–March 2013. London: National Institute for Cardiovascular Outcomes Research; 2013. Available from: http://www.hqip.org.uk/assets/NCAPOP-Library/NCAPOP-2013-14/UCL-HF-2013-Report-2013-ONLINE-v2.pdf (Accessed 19 March 2014)
47. BREATHE Investigators. BREATHE registry—I Brazilian registry of heart failure. Arq Bras Cardiol 2014: In press
48. AlHabib KF, Elasfar AA, AlBackr H et al. Design and preliminary results of the heart function assessment registry trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure. Eur J Heart Fail 2011;13:1178–84
49. Damasceno A, Cotter G, Dzudie A et al. Heart failure in sub-Saharan Africa: time for action. J Am Coll Cardiol 2007;50:1688–93
50. Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 2014;129:e28–e292
51. Townsend N, Wickramasinghe K, Bhatnagar P et al. Coronary Heart Disease Statistics (2012 Edition). London: British Heart Foundation; 2012. Available from: http://www.bhf.org.uk/publications/view-publication.aspx?ps=1002097 (Accessed 21 October 2013)
52. Ceia F, Fonseca C, Mota T et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002;4:531–9
53. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137–46
54. Shiba N, Shimokawa H. Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag 2008;4:103–13
55. Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J 2013;77:2209–17
56. Huffman MD, Prabhakaran D. Heart failure: epidemiology and prevention in India. Natl Med J India 2010;23:283–8
57. Sasayama S. Heart disease in Asia. Circulation 2008;118:2669–71
58. Bocchi EA, Braga FG, Ferreira SM et al. [III Brazilian guidelines on chronic heart failure]. Arq Bras Cardiol 2009;93:3–70
59. Vijayaraghavan G, Sivasankaran S. Tropical endomyocardial fibrosis in India: a vanishing disease! Indian J Med Res 2012;136:729–38
60. Atherton JJ, Hayward CS, Wan Ahmad WA et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail 2012;18:82–8
61. Bocchi EA. Heart failure in South America. Curr Cardiol Rev 2013;9:147–56
62. Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J 2013;34:3538–46
63. Bocchi EA, Marcondes-Braga FG, Bacal F et al. Updating of the Brazilian guideline for chronic heart failure—2012. Arq Bras Cardiol 2012;98:1–33
64. Organisation for Economic Co-operation and Development. Health care utilisation—Hospital discharges by diagnostic categories—All causes Available from: http://stats.oecd.org/(Accessed 28 February 2014)
65. Organisation for Economic Co-operation and Development. General statistics—country statistical profiles—total population, Available from: http://stats.oecd.org/(Accessed 28 February 2014)
66. Organisation for Economic Co-operation and Development. Health care quality indicators—primary care—congestive heart failure hospital admissions, Available from: http://stats.oecd.org/(Accessed 28 February 2014)
67. Stewart S, Wilkinson D, Hansen C et al. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 2008;118:2360–7
68. Khand AU, Shaw M, Gemmel I et al. Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure. Eur J Heart Fail 2005;7:792–7
69. Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010;121:e46–e215
70. Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009;106:269–75
71. World Health Organisation. Spending on health: a global overview (fact sheet N°319): World Health Organisation; 2012. Available from: http://www.who.int/mediacentre/factsheets/fs319/en/ (Accessed 6 May 2014)
72. World Health Organisation. General statistical procedures used to construct WHO health expenditure database. World Health Organisation; 2012. Available from: http://apps.who.int/nha/database/ResourcesPage.aspx (Accessed 6 May 2014)
73. United States Environmental Protection Agency. Drinking water infrastructure needs survey and assessment: fifth report to congress United States Environmental Protection Agency; 2013. Available from: http://water.epa.gov/grants_funding/dwsrf/upload/epa816r13006.pdf (Accessed 19 March 2014)
74. Clark AL. What is heart failure? In McDonagh TA, Gardner RS, Clark AL, Dargie H, eds. Oxford Textbook of Heart Failure. Oxford: Oxford University Press, 2011
75. Thomas JR, Clark AM. Women with heart failure are at high psychosocial risk: a systematic review of how sex and gender influence heart failure self-care. Cardiol Res Pract 2011:918973. doi: 10.4061/2011/918973
76. Jeon YH, Kraus SG, Jowsey T et al. The experience of living with chronic heart failure: a narrative review of qualitative studies. BMC Health Serv Res 2010;10:77. doi: 10.1186/1472-6963-10-77
77. Stromberg A. The situation of caregivers in heart failure and their role in improving patient outcomes. Curr Heart Fail Rep 2013;10:270–5
78. Murray SA, Kendall M, Boyd K et al. Exploring the spiritual needs of people dying of lung cancer or heart failure: a prospective qualitative interview study of patients and their carers. Palliat Med 2004;18:39–45
79. Luttik ML, Blaauwbroek A, Dijker A et al. Living with heart failure: partner perspectives. J Cardiovasc Nurs 2007;22:131–7
80. McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 2012;14:803–69
81. Baker DW. Prevention of heart failure. J Card Fail 2002;8:333–46
82. Endoh M. Heart failure: management and prevention of heart failure based on current understanding of pathophysiological mechanisms. In Wakabayashi I, Groschner K, eds. Interdisciplinary concepts in cardiovascular health. Springer, 2014: 41–67. Available from: http://link.springer.com/chapter/10.1007%2F978-3-319-01074-8_3 (Accessed 25 February 2014)
83. Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 2011;50:187–93
84. Senkus E, Jassem J. Cardiovascular effects of systemic cancer treatment. Cancer Treat Rev 2011;37:300–11
85. Lenihan DJ, Esteva FJ. Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer. Oncologist 2008;13: 1224–34
86. Hidron A, Vogenthaler N, Santos-Preciado JI et al. Cardiac involvement with parasitic infections. Clin Microbiol Rev 2010;23:324–49
87. Pillai HS, Ganapathi S. Heart failure in South Asia. Curr Cardiol Rev 2013;9:102–11
88. Bloomfield GS, Barasa FA, Doll JA et al. Heart failure in sub-Saharan Africa. Curr Cardiol Rev 2013;9:157–73
89. Andrade JP, Marin-Neto JA, Paola AA et al. I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy. Arq Bras Cardiol 2011;97:1–48
90. Schocken DD, Benjamin EJ, Fonarow GC et al. Prevention of heart failure: a scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 2008;117:2544–65
91. Jugdutt BI. Prevention of heart failure in the elderly: when, where and how to begin? Heart Fail Rev 2012;17:531–44
92. Rodriguez-Artalejo F, Banegas Banegas JR, Guallar-Castillon P. Epidemiology of heart failure. Rev Esp Cardiol 2004;57:163–70
93. Hall MJ, Levant S, DeFrances CJ. Hospitalization for congestive heart failure: United States, 2000–2010. NCHS Data Brief 2012:1–8
94. Nieminen MS, Harjola VP, Hochadel M et al. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 2008;10:140–8
95. Sakata Y, Miyata S, Nochioka K et al. Gender differences in clinical characteristics, treatment and long-term outcome in patients with stage C/D heart failure in Japan. Report from the CHART-2 study. Circ J 2014;78:428–35
96. Hawkins NM, Jhund PS, McMurray JJ et al. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail 2012;14:138–46
97. Calvillo-King L, Arnold D, Eubank KJ et al. Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med 2013;28:269–82
98. McSweeney J, Pettey C, Lefler LL et al. Disparities in heart failure and other cardiovascular diseases among women. Women's Health (Lond Engl) 2012;8:473–85
99. Peacock WFt, Fonarow GC, Emerman CL et al. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology 2007;107:44–51
100. Peacock WF, Emerman C, Costanzo MR et al. Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail 2009;15:256–64
101. Maisel AS, Peacock WF, McMullin N et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 2008;52:534–40
102. Gravely-Witte S, Jurgens CY, Tamim H et al. Length of delay in seeking medical care by patients with heart failure symptoms and the role of symptom-related factors: a narrative review. Eur J Heart Fail 2010;12:1122–9
103. Darling C, Saczynski JS, McManus DD et al. Delayed hospital presentation in acute decompensated heart failure: clinical and patient reported factors. Heart Lung 2013;42:281–6
104. Remme WJ, McMurray JJ, Rauch B et al. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J 2005;26:2413–21
105. Johansson P, Nieuwenhuis M, Lesman-Leegte I et al. Depression and the delay between symptom onset and hospitalization in heart failure patients. Eur J Heart Fail 2011;13:214–19
106. Loehr LR, Rosamond WD, Poole C et al. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol 2010;172:781–9
107. Avery CL, Loehr LR, Baggett C et al. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2012;60:1640–6
108. Shroufi A, Chowdhury R, Anchala R et al. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health 2013;13:285. doi:10.1186/1471-2458-13-285
109. Beaglehole R, Bonita R, Horton R et al. Priority actions for the non-communicable disease crisis. Lancet 2011;377:1438–47
110. Mensah GA, Mayosi BM. The 2011 United Nations high-level meeting on non-communicable diseases: the Africa agenda calls for a 5-by-5 approach. S Afr Med J 2013;103:77–9
111. Sliwa K, Mayosi BM. Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart 2013;99:1317–22
112. Mpe MT, Klug EQ, Silwa KS et al. Heart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline. S Afr Med J 2013;103:660–7
113. Japanese Circulation Society. Guidelines for treatment of acute heart failure (JCS 2011). Circ J 2013;77:2157–201
114. Okuda S, Yano M. Guidelines for treatment of chronic heart failure (JCS 2010). Nihon Rinsho 2011;69(Suppl 9):595–604
115. Ministry of Health. Clinical practice guidelines—heart failure. Ministry of Health, Singapore; 2004. Available from: http://www.moh.gov.sg/content/dam/moh_web/HPP/Doctors/cpg_medical/withdrawn/cpg_Heart%20Failure-Aug%202004.pdf (Accessed 25 February 2014)
116. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia—updated October 2011; 2011. Available from: http://www.heartfoundation.org.au/SiteCollectionDocuments/Chronic_Heart_Failure_Guidelines_2011.pdf (Accessed 4 December 2013)
117. National Institute for Health and Care Excellence. Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. NICE clinical guideline 108; 2010. Available from: guidance.nice.org.uk/cg108/ (Accessed 21 October 2013)
118. Scottish Intercollegiate Guidelines Network. Management of chronic heart failure: a national clinical guideline. Edinburgh, UK: SIGN; 2007. Available from: http://sign.ac.uk/pdf/sign95.pdf (Accessed 26 February 2014)
119. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Herzinsuffizienz: DEGAM Leitlinie Nr. 9. Düsseldorf: Omikron; 2006. Available from: http://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/LL-09_Langfassung_Herzinsuffizienz_1_E002BIndex.pdf (Accessed 26 February 2014)
120. Haute Autorité de Santé. Insuffisance cardiaque à fraction d'éjection préservée HAS; 2012. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/liste_ald_insuf_cardaique_diastolique.pdf (Accessed 24 February 2014)
121. Haute Autorité de Santé. Insuffisance cardiaque systolique. HAS; 2012. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/liste_ald_insuf_card_systolique.pdf (Accessed 24 February 2014)
122. Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;128:e240–e327
123. Lindenfeld J, Albert NM, Boehmer JP et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010;16:e1–194
124. McKelvie RS, Moe GW, Ezekowitz JA et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 2013;29:168–81
125. National Guideline Clearinghouse. Guideline synthesis: diagnosis and evaluation of chronic heart failure (CHF). Rockville (MD): Agency for Healthcare Research and Quality; 2012. Available from: http://www.guideline.gov/syntheses/synthesis.aspx? id=36850 (Accessed 25 February 2014)
126. Komajda M, Lapuerta P, Hermans N et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005;26:1653–9
127. Fonarow GC, Abraham WT, Albert NM et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007;297:61–70
128. Frankenstein L, Remppis A, Fluegel A et al. The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail 2010;12:574–80
129. Williams SC, Schmaltz SP, Morton DJ et al. Quality of care in US hospitals as reflected by standardized measures, 2002–2004. N Engl J Med 2005;353:255–64
130. Lee DS, Johansen H, Gong Y et al. Regional outcomes of heart failure in Canada. Can J Cardiol 2004;20:599–607
131. Stewart S, Demers C, Murdoch DR et al. Substantial between-hospital variation in outcome following first emergency admission for heart failure. Eur Heart J 2002;23:650–7
132. Rohde LE, Clausell N, Ribeiro JP et al. Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States. Int J Cardiol 2005;102:71–7
133. Atherton JJ. Chronic heart failure: we are fighting the battle, but are we winning the war? Scientifica 2012;2012:16. doi: 10.6064/2012/279731
134. Komajda M, Follath F, Swedberg K et al. The EuroHeart failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24: 464–74
135. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation 2008;118:1383–93
136. Bradley EH, Curry L, Horwitz LI et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol 2012;60:607–14
137. Jaarsma T, Stromberg A, De Geest S et al. Heart failure management programmes in Europe. Eur J Cardiovasc Nurs 2006;5:197–205
138. Gravely S, Ginsburg L, Stewart DE et al. Referral and use of heart failure clinics: what factors are related to use? Can J Cardiol 2012;28:483–9
139. Heidenreich PA, Hernandez AF, Yancy CW et al. Get with the guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure. Circ Cardiovasc Qual Outcomes 2012;5:37–43
140. Rohde LE, Bertoldi EG, Goldraich L et al. Cost-effectiveness of heart failure therapies. Nat Rev Cardiol 2013;10:338–54
141. Shiba N, Nochioka K, Miura M et al. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan—first report from the CHART-2 study. Circ J 2011;75:823–33
142. Kociol RD, Peterson ED, Hammill BG et al. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get with the guidelines—heart failure registry. Circ Heart Fail 2012;5:680–7
143. The Joint Commission. Heart failure; 2014. Available from: http://www.jointcommission.org/heart_failure/ (Accessed 21 March 2014)
144. Joynt KE, Jha AK. Thirty-day readmissions—truth and consequences. N Engl J Med 2012;366:1366–9
145. National Institute for Health and Care Excellence. About the quality and outcomes framework (QOF); 2014. Available from: http://www.nice.org.uk/aboutnice/qof/qof.jsp (Accessed 21 March 2014)
146. Health and Social Care Information Centre. Indicators for quality improvement; 2014. Available from: https://mqi.ic.nhs.uk/Search.aspx?query=heart%25failure (Accessed 21 March 2014 2014)
147. Kul S, Barbieri A, Milan E et al. Effects of care pathways on the in-hospital treatment of heart failure: a systematic review. BMC Cardiovasc Disord 2012;12:81. doi: 10.1186/1471-2261-12-81
148. Mondoa C, Cappie J, Kennedy F et al. This bundle saves lives! Outcomes from a heart failure bundle in acute care. NHSScotland Event; 2013, Glasgow, UK. Available from: http://www.nhsscotlandevent.com/posters/Posters-2013/Effective/EF20_-_Catherine_Labinjoh.pdf (Accessed 21 March 2014)
149. Butler J, Fonarow GC, Gheorghiade M. Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure. JAMA 2013;310:2035–6
150. Lee DS, Ezekowitz JA. Risk stratification in acute heart failure. Can J Cardiol 2014;30:312–19
151. Burkhoff D. Mortality in heart failure with preserved ejection fraction: an unacceptably high rate. Eur Heart J 2012;33:1718–20
152. Pollesello P. Drug discovery and development for acute heart failure drugs: are expectations too high? Int J Cardiol 2014;172:11–13
153. Metra M, Ponikowski P, Dickstein K et al. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007;9:684–94
154. Gheorghiade M, Vaduganathan M, Fonarow GC et al. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 2013;61:391–403
155. Braunstein JB, Anderson GF, Gerstenblith G et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226–33
156. Sliwa K, Bohm M. Incidence and prevalence of pregnancy-related heart disease. Cardiovasc Res 2014;101:554–60
157. Sliwa K, Mocumbi AO. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol 2010;99:65–74
158. Palaniswamy C, Mishkin A, Aronow WS et al. Remote patient monitoring in chronic heart failure. Cardiol Rev 2013;21:141–50
159. Pandor A, Gomersall T, Stevens JW et al. Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis. Heart 2013;99:1717–26
160. Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 2011;378:731–9
161. Thomas R, Huntley A, Mann M et al. Specialist clinics for reducing emergency admissions in patients with heart failure: a systematic review and meta-analysis of randomised controlled trials. Heart 2013;99:233–9
162. McAlister FA, Stewart S, Ferrua S et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004;44:810–9
163. Stamp KD, Machado MA, Allen NA. Transitional care programs improve outcomes for heart failure patients: an integrative review. J Cardiovasc Nurs 2014;29:140–54
164. Jaarsma T, Beattie JM, Ryder M et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433–43
165. Riegel B, Moser DK, Anker SD et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation 2009;120:1141–63
166. Jaarsma T, Stromberg A, Ben Gal T et al. Comparison of self-care behaviors of heart failure patients in 15 countries worldwide. Patient Educ Couns 2013;92:114–20
167. Nieuwenhuis MM, Jaarsma T, van Veldhuisen DJ et al. Factors associated with patient delay in seeking care after worsening symptoms in heart failure patients. J Card Fail 2011;17:657–63
168. United Nations. Deputy UN chief calls for urgent action to tackle global sanitation crisis; 2013. Available from: http://www.un.org/apps/news/story.asp?NewsID=44452#.U0LFEvldUmM (Accessed 7 April 2014)
169. Gallagher R, Luttik ML, Jaarsma T. Social support and self-care in heart failure. J Cardiovasc Nurs 2011;26:439–45